CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4505-4512

  Chen, Chia Geun ^a,b   Yang, Yun Liang ^c   Shih, Hsin I ^c   Su, Chia Li ^b   Lo, Hsiu Jung ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER CDR1; ANTIFUNGAL AGENT; BETA GALACTOSIDASE; FLUCONAZOLE; KETOCONAZOLE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CANDT80; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGAL STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; SACCHAROMYCES CEREVISIAE; WILD TYPE;

BASE SEQUENCE; CANDIDA ALBICANS; CLONING, MOLECULAR; CULTURE MEDIA; DNA, FUNGAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; KETOCONAZOLE; LAC OPERON; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 9644283078     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4505-4512.2004     Document Type: Article

References (36)

1. Christianson, T. W., R. S. Sikorski, M. Dante, J. H. Shero, and P. Hieter. 1992. Multifunctional yeast high-copy-number shuttle vectors. Gene 110:119-122.
2. Chu, S., J. DeRisi, M. Eisen, J. Mulholland, D. Botstein, P. O. Brown, and I. Herskowltz. 1998. The transcriptional program of sporulation in budding yeast. Science 282:699-705.
3. Chu, S., and I. Herskowitz. 1998. Gametogenesis in yeast is regulated by a transcriptional cascade dependent on Ndt80. Mol. Cell 1:685-696.
4. De Backer, M. D., T. Ilyina, X. J. Ma, S. Vandoninck, W. H. Luyten, and H. Vanden Bossche. 2001. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45:1660-1670.
5. de Micheli, M., J. Bille, C. Schueller, and D. Sanglard. 2002. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43:1197-1214.
6. Edwards, E. J. J. 1990, Candida species, p. 1943-1958. In G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
7. Gerami-Nejad, M., J. Herman, and C. A. Gale. 2001. Cassettes for PCR-mediated construction of green, yellow, and cyan fluorescent protein fusions in Candida albicans. Yeast 18:859-864.
8. Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
9. Karababa, M., A. T. Coste, B. Rognon, J. Bille, and D. Sanglard. 2004. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob. Agents Chemother. 48:3064-3079.
10. Kiemer, A. K., K. Takeuchi, and M. P. Quinlan. 2001. Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene 20:6679-6688.
11. Kofron, M., T. Demel, J. Xanthos, J. Lohr, B. Sun, H. Sive, S. Osada, C. Wright, C. Wylie, and J. Heasman. 1999. Mesoderm induction in Xenopus is a zygotic event regulated by maternal VegT via TGFbeta growth factors. Development 126:5759-5770.
12. Kohler, J. R., and G. R. Fink. 1996. Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc. Natl. Acad. Sci. USA 93:13223-13228.
13. Lamoureux, J. S., D. Stuart, R. Tsang, C. Wu, and J. N. Glover. 2002. Structure of the sporulation-specific transcription factor Ndt80 bound to DNA. EMBO J. 21:5721-5732.
14. Liang, Y., S. McDonnell, and M. Clynes. 2002. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr. Cancer Drug Targets 2:257-277.
15. Liu, H., J. Kohler, and G. R. Fink. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266:1723-1726.
16. Lo, H. J., J. R. Kohler, B. DiDornenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
17. Lopez-Ribot, J. L., R. K. McAtee, L. N. Lee, W. R. Kirkpatrick, T. C. White, D. Sanglard, and T. F. Pattersori. 1998. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42:2932-2937.
18. Marger, M. D., and M. H. Saier, Jr. 1993. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem. Sci. 18:13-20.
19. Michaelis, S., and C. Berkower, 1995. Sequence comparison of yeast ATP-binding cassette proteins. Cold Spring Harbor Symp. Quant. Biol. 60:291-307.
20. Montano, S. P., M. L. Cote, I. Fingerman, M. Pierce, A. K. Vershon, and M. M. Georgiadis. 2002. Crystal structure of the DNA-binding domain from Ndt80, a transcriptional activator required for meiosis in yeast. Proc. Natl. Acad. Sci. USA 99:14041-14046.
21. Mosch, H. U., R. L. Roberts, and G. R. Fink. 1996. Ras2 signals via the Cdc42/Ste20/mitogen-activated protein kinase module to induce filamentous growth in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 93:5352-5356.
22. Myers, A. M., A. Tzagoloff, D. M. Kinney, and C. J. Lusty. 1986. Yeast shuttle and integrative vectors with multiple cloning sites suitable for construction of lacZ fusions. Gene 45:299-310.
23. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis. 2003. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol. 41:1440-1446.
24. Pfaller, M. A., R. N. Jones, G. V. Doern, H. S. Sader, S. A. Messer, A. Houston, S. Coffman, and R. J. Hollis. 2000. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob. Agents Chemother. 44:747-751.
25. Prasad, R., P. De Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
26. Puri, N., S. Krishnamurthy, S. Habib, S. E. Hasnain, S. K. Goswami, and R. Prasad. 1999. CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. FEMS Microbiol. Lett. 180:213-219.
27. Reynolds, A., V. Lundblad, D. Dorris, and M. Keaveney. 1997. Yeast vectors and assays for expression of cloned genes, p. 13.6.1-13.6.6. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
28. Sahin, A. A. 2000. Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv. Anat. Pathol. 7:158-166.
29. Sanglard, D., F. Ischer, M. Monod. and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305.
30. Sherman, F. 2002. Getting started with yeast. Methods Enzymol. 350:3-41.
31. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
32. Tapia, C., E. Leon, and E. Palavecino. 2003. Antifungal susceptibility of yeasts by Etest. Comparison of 3 media. Rev. Med. Chil. 131:299-302.
33. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, G. S. Sen, L. Improvisi, P. Marichal, F. C. Odds, F. Provost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32(Suppl. 1):189-202.
34. Wilson, R. B., D. Davis, B. M. Enloe, and A. P. Mitchell. 2000. A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions. Yeast 16:65-70.
35. Wilson, R. B., D. Davis, and A. P. Mitchell. 1999. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J. Bacteriol. 181:1868-1874.
36. Yang, Y. L., and H.-J. Lo. 2001. Mechanisms of antifungal agent resistance. J. Microbiol. Immunol. Infect. 34:79-86.